Skip to main content
NewslettersWatchlist

Vext Science Inc(VEXT-CN)
CSE

Today's Change
Delayed Last Update
Day Low0.1800
Day High0.1900
Open:0.1900
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Newsfile
Vext Engages PartnerCap Securities, LLC
Newsfile
Vext Announces Financial Results for Q2 2024
Baystreet
Inflation Figures Due in Canada Next Week
Newsfile
Vext to Announce Financial Results for Q2 2024 on August 20, 2024
Newsfile
Vext to Commence Adult-Use Cannabis Sales in Ohio on August 6
Newsfile
Vext Secures Dual-Use Provisional Licenses, Nears Launch of Adult-Use Cannabis Sales in Ohio
Newsfile
Vext Announces Financial Results for Q1 2024
Newsfile
Vext to Announce Financial Results for Q1 2024 on May 29, 2024
Newsfile
Vext Reports Financial Results for Q4 and Fiscal 2023
Newsfile
Vext Announces Revised Date for Q4 and Fiscal 2023 Financial Results Release
Newsfile
Vext Announces Delay of Annual Filings and Postponement of Conference Call
Newsfile
Vext to Announce Financial Results for Q4 and Fiscal 2023 on April 25, 2024
Newsfile
Vext Strengthens Ohio Presence with Dispensary Property Acquisition
Newsfile
Vext Announces Change of Auditor
Newsfile
Vext Announces Closing of Debt Conversion Transaction
Newsfile
Vext Completes Acquisition of Columbus Dispensary, Strengthens Vertically Integrated Position in Ohio
Newsfile
Vext Engages Zuanic & Associates
Newsfile
Vext Announces Transition of Jason Thai Nguyen out of Executive Role
Newsfile
Vext Announces Exchange of $4.6 Million Debt for Common Shares
Newsfile
Vext Announces Voting Results of Annual General Meeting and Strengthens Board
Newsfile
Vext Reports Financial Results for Q3 2023
Newsfile
Vext to Announce Financial Results for Q3 2023 on November 28, 2023

Profile

Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The Company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.